D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity

BACKGROUND: Dysregulation of N-methyl D-aspartate (NMDA) receptor signaling is strongly implicated in schizophrenia. Based on the ketamine model of NMDA receptor hypoactivity, therapeutic approaches designed to maintain a sustained increase in agonist activity at the glycine site of the NMDA recepto...

Descripción completa

Detalles Bibliográficos
Autor principal: Goff, Donald C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327448/
https://www.ncbi.nlm.nih.gov/pubmed/26915421
http://dx.doi.org/10.2174/1570159X14666160225154812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327448/
https://www.ncbi.nlm.nih.gov/pubmed/26915421
http://dx.doi.org/10.2174/1570159X14666160225154812

Ejemplares similares